PT UBC Medical Indonesia Tbk
PT UBC Medical Indonesia Tbk distributes medical devices in Indonesia. It operates in two segments, Medical Disposables and Consumables, and Diagnostics and Equipment. The company offers next generation molecular, retina AI, infectious disease, HPV DNA test, real time PCR, TB management, and newborn screening products. PT UBC Medical Indonesia Tbk was founded in 2014 and is based in Jakarta Timur… Read more
PT UBC Medical Indonesia Tbk (LABS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.063x
Based on the latest financial reports, PT UBC Medical Indonesia Tbk (LABS) has a cash flow conversion efficiency ratio of 0.063x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp9.43 Billion) by net assets (Rp150.72 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
PT UBC Medical Indonesia Tbk - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how PT UBC Medical Indonesia Tbk's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
PT UBC Medical Indonesia Tbk Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of PT UBC Medical Indonesia Tbk ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PT Jobubu Jarum Minahasa Tbk
JK:BEER
|
-0.001x |
|
Magna Prima Bhd
KLSE:7617
|
0.155x |
|
Celyad Oncology SA
PINK:CLYYF
|
0.919x |
|
Total Metals Corp.
V:TT
|
N/A |
|
Hapbee Technologies Inc
PINK:HAPBF
|
0.979x |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
-0.039x |
|
PT Hasnur Internasional
JK:HAIS
|
0.073x |
|
Barksdale Resources Corp
OTCQX:BRKCF
|
-0.058x |
Annual Cash Flow Conversion Efficiency for PT UBC Medical Indonesia Tbk (2021–2024)
The table below shows the annual cash flow conversion efficiency of PT UBC Medical Indonesia Tbk from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp138.75 Billion | Rp-13.68 Billion | -0.099x | +67.18% |
| 2023-12-31 | Rp49.36 Billion | Rp-14.83 Billion | -0.300x | +5.23% |
| 2022-12-31 | Rp47.47 Billion | Rp-15.05 Billion | -0.317x | +85.82% |
| 2021-12-31 | Rp9.23 Billion | Rp-20.63 Billion | -2.235x | -- |